FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF
Authors
Publication date
1 January 2005
Publisher
Abstract
The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.published_or_final_versio
